Lactoferrin
Potent antiviral and antibiotic: Inhibits HSV, CMV, EBV, E coli, UTI bacteria (in mice), numerous other viruses and bacteria. Improved sleep quality, reduced the occurrence of depressive-mood in a human RCT. Improved intra-abdominal (visceral) fat, BMI and hip circumference in a human RCT. Was used as part of a successful Myelofibrosis treatment (single case study). In a Phase II clinical trial against advanced RCC, the treatment group got 21 months median survival on recombinant lactoferrin alone. This compares favorably with the RCC historical cohort, which have exhausted all other options. Stimulated the immune system, extended lifespan, and reduced amyloid β peptide toxicity in C elegans. Considered to be one of the key molecules responsible for the benefits of Mother’s milk (anticancer, antiviral, antibacterial). Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma ( link ) Background: Talactoferrin (TLF),...